1
|
Muraoka M, Ohno M, Nakai T, Matsuura H, Nagano K, Arai M, Hirata Y, Uyama H, Hirata K. Gamma-Glutamylcysteine Production Using Phytochelatin Synthase-Like Enzyme Derived from <i>Nostoc</i> sp. Covalently Immobilized on a Cellulose Carrier. Biol Pharm Bull 2022; 45:1191-1197. [DOI: 10.1248/bpb.b22-00316] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Affiliation(s)
- Misa Muraoka
- Applied Environmental Biology Laboratory, Graduate School of Pharmaceutical Sciences, Osaka University
| | - Moeka Ohno
- Applied Environmental Biology Laboratory, Graduate School of Pharmaceutical Sciences, Osaka University
| | - Takuya Nakai
- Applied Environmental Biology Laboratory, Graduate School of Pharmaceutical Sciences, Osaka University
| | - Hideyuki Matsuura
- Applied Environmental Biology Laboratory, Graduate School of Pharmaceutical Sciences, Osaka University
| | - Kazuya Nagano
- School of Pharmaceutical Sciences, Wakayama Medical University
| | - Masayoshi Arai
- Natural Products for Drug Discovery Laboratory, Graduate School of Pharmaceutical Sciences, Osaka University
| | | | - Hiroshi Uyama
- Department of Applied Chemistry, Graduate School of Engineering, Osaka University
| | - Kazumasa Hirata
- School of Pharmaceutical Sciences, Wakayama Medical University
| |
Collapse
|
2
|
Haniffa MACM, Munawar K, Chee CY, Pramanik S, Halilu A, Illias HA, Rizwan M, Senthilnithy R, Mahanama KRR, Tripathy A, Azman MF. Cellulose supported magnetic nanohybrids: Synthesis, physicomagnetic properties and biomedical applications-A review. Carbohydr Polym 2021; 267:118136. [PMID: 34119125 DOI: 10.1016/j.carbpol.2021.118136] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/30/2020] [Revised: 04/24/2021] [Accepted: 04/27/2021] [Indexed: 12/27/2022]
Abstract
Cellulose and its forms are widely used in biomedical applications due to their biocompatibility, biodegradability and lack of cytotoxicity. It provides ample opportunities for the functionalization of supported magnetic nanohybrids (CSMNs). Because of the abundance of surface hydroxyl groups, they are surface tunable in either homogeneous or heterogeneous solvents and thus act as a substrate or template for the CSMNs' development. The present review emphasizes on the synthesis of various CSMNs, their physicomagnetic properties, and potential applications such as stimuli-responsive drug delivery systems, MRI, enzyme encapsulation, nucleic acid extraction, wound healing and tissue engineering. The impact of CSMNs on cytotoxicity, magnetic hyperthermia, and folate-conjugates is highlighted in particular, based on their structures, cell viability, and stability. Finally, the review also discussed the challenges and prospects of CSMNs' development. This review is expected to provide CSMNs' development roadmap in the context of 21st-century demands for biomedical therapeutics.
Collapse
Affiliation(s)
| | - Khadija Munawar
- Centre of Advanced Manufacturing and Material Processing, Faculty of Engineering, University of Malaya, 50603 Kuala Lumpur, Malaysia.
| | - Ching Yern Chee
- Centre of Advanced Manufacturing and Material Processing, Faculty of Engineering, University of Malaya, 50603 Kuala Lumpur, Malaysia; Department of Chemical Engineering, Faculty of Engineering, University of Malaya, 50603 Kuala Lumpur, Malaysia.
| | - Sumit Pramanik
- Functional and Biomaterials Engineering Lab, Department of Mechanical Engineering, Faculty of Engineering and Technology, SRM Institute of Science and Technology, Kattankulathur, Kancheepuram, 603203, Chennai, Tamil Nadu, India.
| | - Ahmed Halilu
- Department of Chemical Engineering, Faculty of Engineering, University of Malaya, 50603 Kuala Lumpur, Malaysia
| | - Hazlee Azil Illias
- Centre of Advanced Manufacturing and Material Processing, Faculty of Engineering, University of Malaya, 50603 Kuala Lumpur, Malaysia; Department of Electrical Engineering, Faculty of Engineering, University of Malaya, 50603 Kuala Lumpur, Malaysia.
| | - Muhammad Rizwan
- Department of Chemistry, The University of Lahore, Lahore, Pakistan
| | - Rajendram Senthilnithy
- Department of Chemistry, Faculty of Natural Sciences, The Open University of Sri Lanka, 10250 Nawala, Nugegoda, Sri Lanka
| | | | - Ashis Tripathy
- Center for MicroElectroMechanics Systems (CMEMS), University of Minho, Campus de Azurém, 4800-058 Guimarães, Portugal
| | - Mohd Fahmi Azman
- Physics Division, Centre for foundation studies, University of Malaya, 50603 Kuala Lumpur, Malaysia
| |
Collapse
|
3
|
Flow Biocatalysis: A Challenging Alternative for the Synthesis of APIs and Natural Compounds. Int J Mol Sci 2021; 22:ijms22030990. [PMID: 33498198 PMCID: PMC7863935 DOI: 10.3390/ijms22030990] [Citation(s) in RCA: 33] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Abstract] [Key Words] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2020] [Revised: 01/13/2021] [Accepted: 01/14/2021] [Indexed: 01/01/2023] Open
Abstract
Biocatalysts represent an efficient, highly selective and greener alternative to metal catalysts in both industry and academia. In the last two decades, the interest in biocatalytic transformations has increased due to an urgent need for more sustainable industrial processes that comply with the principles of green chemistry. Thanks to the recent advances in biotechnologies, protein engineering and the Nobel prize awarded concept of direct enzymatic evolution, the synthetic enzymatic toolbox has expanded significantly. In particular, the implementation of biocatalysts in continuous flow systems has attracted much attention, especially from industry. The advantages of flow chemistry enable biosynthesis to overcome well-known limitations of “classic” enzymatic catalysis, such as time-consuming work-ups and enzyme inhibition, as well as difficult scale-up and process intensifications. Moreover, continuous flow biocatalysis provides access to practical, economical and more sustainable synthetic pathways, an important aspect for the future of pharmaceutical companies if they want to compete in the market while complying with European Medicines Agency (EMA), Food and Drug Administration (FDA) and green chemistry requirements. This review focuses on the most recent advances in the use of flow biocatalysis for the synthesis of active pharmaceutical ingredients (APIs), pharmaceuticals and natural products, and the advantages and limitations are discussed.
Collapse
|